Skip to content

Clinical trials

Recruiting Phase 2 Glomerulonephritis, IGA trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulonephritis, IGA Phase: Phase 2 Status: Recruiting Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20201
20211
20231
20242
20256
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ADARx Pharmaceuticals, Inc.2
Novartis Pharmaceuticals2
Akebia Therapeutics1
Centre Hospitalier Universitaire de Saint Etienne1
Chengdu Suncadia Medicine Co., Ltd.1
Everest Medicines (China) Co.,Ltd.1
Guangdong Hengrui Pharmaceutical Co., Ltd1
Haisco Pharmaceutical Group Co., Ltd.1
Jade Biosciences, Inc.1
Keymed Biosciences Co.Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulonephritis, IGA18
Autoimmune Diseases3
Glomerulonephritis3
Immune System Diseases3
Kidney Diseases3
Nephrosis, Lipoid3
Proteinuria3
Glomerulosclerosis, Focal Segmental2
Nephritis2
Diabetic Nephropathies1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.